Inhibition of sphingolipid synthesis impairs cellular activation, cytokine production and proliferation in human lymphocytes

Biochem Pharmacol. 2005 Dec 19;71(1-2):126-35. doi: 10.1016/j.bcp.2005.10.004. Epub 2005 Nov 2.

Abstract

The localisation of the T cell receptor and other signalling molecules in membrane microdomains (MM) is essential for the activation of T lymphocytes. These MM are stabilized by sphingolipids and cholesterol. It was recently shown that the activation of T lymphocytes leads to the confluence of small MM and the formation of an immunological synapse which is thought to be essential for a persistent activation and proliferation. We studied the effects of an inhibition of sphingolipid synthesis on T lymphocyte function. Both sphingolipid inhibitors, PDMP and myriocin, inhibited glucosphingolipids in whole cell lipid extracts and in MM. Both compounds inhibited the proliferation of superantigen-stimulated PBMC without inducing cell death. However, only the ceramide-like compound PDMP inhibited the expression of activation markers and the secretion of IFN-gamma which was not seen with myriocin treatment. The MM localisation of Lck and LAT was not significantly reduced in PDMP-treated cells. In conclusion, our results show that glucosphingolipids are necessary for cell growth of human T lymphocytes. However, inhibition of glucosphingolipid synthesis itself did not inhibit cellular activation. Our data show that glucosphingolipids - in contrast to cholesterol - are not essential for the stabilisation of MM.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Division / drug effects
  • Cell Proliferation / drug effects*
  • Chromatography, Thin Layer
  • Cytokines / biosynthesis*
  • Humans
  • Lymphocyte Activation / drug effects
  • Lymphocytes / drug effects*
  • Lymphocytes / metabolism
  • Membrane Microdomains
  • Morpholines / pharmacology
  • Sphingolipids / biosynthesis*

Substances

  • Cytokines
  • Morpholines
  • Sphingolipids
  • RV 538